期刊文献+

奥美拉唑联合西沙必利治疗返流性食管炎的疗效观察 被引量:4

下载PDF
导出
摘要 目的:观察奥美拉唑联合西沙必利治疗返流性食管炎的临床疗效。方法:将85例返流性食管炎患者随机分成三组,治疗组(奥美拉唑+西沙必利)30例,奥美拉唑20mg每晨口服,同时西沙必利5mg每日3次餐前服;奥美拉唑对照组28例,仅奥美拉唑20mg每晨口服;西沙必利对照组27例,仅西沙必利5mg每日3次餐前服。三组疗程均至少8周。结果:治疗组显效率及总有效率均明显高于对照组(P<0.05)。结论:奥美拉唑联合西沙必利治疗返流性食管炎较单独用药临床疗效更加显著。
作者 黄国胜
出处 《实用医技杂志》 2006年第4期562-563,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献2

共引文献88

同被引文献28

  • 1黄飚.81例返流性食管炎胃镜检查分析[J].实用医技杂志,2008,15(4):471-472. 被引量:2
  • 2李军,吴本俨.长期质子泵抑制剂治疗老年反流性食管炎11例[J].世界华人消化杂志,2006,14(15):1524-1526. 被引量:15
  • 3Lundell L,Miettinen P,Myrvold H E,et al.Continued (5-year) follow up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease[J].J Am Coll Surg,2001,192(2):172-179. 被引量:1
  • 4Jeong H Y,Lee B S,Sung J K,et al.A randomized,prospective,comparative,multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis[J].Korean J Gastroenterol,2006,47(1):15-21. 被引量:1
  • 5Rackoff A,Agrawal A,Hila A,et al.Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy[J].Dis Esophagus,2005,18(6):370-373. 被引量:1
  • 6Westbrook J I,Talley N J.Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics:a population-based study of 2300 Australians[J].Aliment Pharmacol Ther,2003,17(9):1171-1178. 被引量:1
  • 7Chen Y K,Raijman I,Ben-Menachem T,et al.Long-term outcomes of endoluminal gastroplication:a U.S.multicenter trial[J].Gastrointest Endosc,2005,61(6):659-667. 被引量:1
  • 8Remak E,Brown R E,Yuen C,et al.Cost-effectiveness comparison of current proton-pump inhibitors to treat gastro-oesophageal reflux disease in the UK[J].Curr Med Res Opin,2005,21(10):1505-1517. 被引量:1
  • 9Habu Y,Maeda K,Kusuda T,et al."Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis:a cost-effectiveness analysis in Japan[J].J Gastroenterol,2005,40(11):1029-1035. 被引量:1
  • 10Talley N J,Venables T L,Green J R,et al.Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease:a placebo-controlled trial of on-demand therapy for 6 months[J].Eur J Gastroenterol Hepatol,2002,14(8):857-863. 被引量:1

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部